Peter Verwaijen
Ventas & Marketing en EGETIS THERAPEUTICS AB .
Cargos activos de Peter Verwaijen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Ventas & Marketing | 05/05/2022 | - |
Historial de carrera de Peter Verwaijen
Antiguos cargos conocidos de Peter Verwaijen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Director Financiero/CFO | 17/04/2009 | - |
Glaucus Proteomics BV
 Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Comptroller/Controller/Auditor | - | - |
Estadísticas
Internacional
| Países Bajos | 3 |
| Suecia | 2 |
Operativa
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Sales & Marketing | 1 |
Sectorial
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Verwaijen
- Experiencia
